| 多西他赛为主方案治疗非小细胞肺癌35例分析 |
| |
| 引用本文： | 杨玲.多西他赛为主方案治疗非小细胞肺癌35例分析[J].蚌埠医学院学报,2008,33(3):301-302. |
| |
| 作者姓名： | 杨玲 |
| |
| 作者单位： | 安徽省蚌埠市第三人民医院呼吸内科, 233000 |
| |
| 摘 要： | 目的:观察以多西他赛为主方案治疗非小细胞肺癌的疗效。方法:35例非小细胞肺癌用多西他赛100 mg d1静脉滴注,分别配伍顺铂100 mg或奥沙利铂200 mg,静脉滴注d1,3周为1周期,4周期后按WHO标准评价疗效。结果:35例中CR 1例,PR 21例,NC 10例,PD 3例,总有效率(CR+PR)62.86%。主要毒副作用是骨髓抑制、消化道反应和脱发。结论:多西他赛为主方案是目前治疗非小细胞肺癌的安全可靠方案。
|
| 关 键 词： | 肺肿瘤 癌 非小细胞肺 肿瘤/药物疗法 多西他赛 |
| 文章编号： | 1000-2200(2008)03-0301-02 |
| 收稿时间： | 2007-01-24 |
| 修稿时间： | 2007年1月24日 |
Docetaxel combination therapy for treatment of non-small cell lung cancer:Report of 35 cases |
| |
| YANG Ling.Docetaxel combination therapy for treatment of non-small cell lung cancer:Report of 35 cases[J].Journal of Bengbu Medical College,2008,33(3):301-302. |
| |
| Authors: | YANG Ling |
| |
| Institution: | Department of Respiratory Diseases, Bengbu Third People's Hospital, Bengbu Anhui 233000, China |
| |
| Abstract: | Objective:To observe the efficacy and side effect of docetaxel combination therapy on advanced non-small-cell lung cancer(NSCLC).Methods:Thirty-five patients with NSCLC were treated by docetaxel 100 mg intravenous d1,combined with cisplatin 100 mg or oxaliplatin intravenous 200 mg d1,respectively.The therapy was repeated every 3 weeks.After 4 cycles the effects and side effects were evaluated by WHO criteria.Results:CR was achieved in 1,PR in 21,NC in 10 and PD in 3.The overall response rate(CR+PR) was 62.8... |
| |
| Keywords: | lung neoplasms cancer non-small cell lung neoplasms/drug therapy docetaxe |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
| 点击此处可从《蚌埠医学院学报》浏览原始摘要信息 |
| 点击此处可从《蚌埠医学院学报》下载免费的PDF全文 |
|
